Loading articles...

Initial public offerings scheduled to debut next week

NEW YORK — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

Week of July 15.

Afya – Nova Lima, Brazil, 13.7 million shares, priced $16-$18, managed by BofA Merrill Lynch. Proposed Nasdaq symbol AFYA. Business: Brazilian for-profit medical and healthcare education group.

AssetMark Financial Holdings – Concord, Calif., 12.5 million shares, priced $19-$21, managed by JP Morgan/Goldman Sachs. Proposed NYSE symbol AMK. Business: Provides a wealth management platform for independent financial advisers.

DouYu International Holdings – Wuhan, China, 67.4 million shares, priced $11.50-$14, managed by Morgan Stanley/JP Morgan. Proposed Nasdaq symbol DOYU. Business: Tencent-backed live e-sports streaming platform.

Fulcrum Therapeutics – Cambridge, Mass., 4.5 million shares, priced $16-$18, managed by Morgan Stanley/BofA Merrill Lynch. Proposed Nasdaq symbol FULC. Business: Developing small molecule therapies based on gene regulation for rare diseases.

Genmab – Copenhagen, Denmark, 27.8 million shares, priced at $18.11, managed by BofA Merrill Lynch/Morgan Stanley. Proposed Nasdaq symbol GMAB. Business: Developing novel antibodies for cancer and other diseases.

Health Catalyst – Salt Lake City, Utah, 6 million shares, priced $20-$23, managed by Goldman Sachs/JP Morgan. Proposed Nasdaq symbol HCAT. Business: Provides a data analytics platform and services to healthcare organizations.

Intercorp Financial Services – Lima, Peru, 9 million shares, priced $44-$50, managed by BofA Merrill Lynch/JP Morgan. Proposed NYSE symbol IFS. Business: Leading bank, insurer and wealth manager in Peru.

Medallia – San Francisco, 14.5 million shares, priced $16-$18, managed by BofA/Merrill Lynch. Proposed NYSE symbol MDLA. Business: Provides enterprise software used to analyze and improve user experience.

Mirum Pharmaceuticals – 5 million shares, priced $14-$16, managed by Citi/Evercore ISI. Proposed Nasdaq symbol MIRM. Business: Late-stage biotech developing therapies for rare cholestatic liver diseases.

Phreesia – New York, 7.8 million shares, priced $15-$17, managed by JP Morgan/Wells Fargo Securities. Proposed NYSE symbol PHR. Business: Provides a patient-intake software platform for healthcare provides.

Sunnova Energy International – Houston, 17.6 million shares, priced $16-$18, managed by BofA Merrill Lynch/JP Morgan. Proposed NYSE symbol NOVA. Business: Provides residential solar energy systems and services.

The Associated Press

Join the conversation

Please read our commenting policies

This site uses Akismet to reduce spam. Learn how your comment data is processed.